Growth Metrics

Innoviva (INVA) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $41.0 million.

  • Innoviva's Operating Expenses rose 3759.15% to $41.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.2 million, marking a year-over-year increase of 1366.15%. This contributed to the annual value of $321.3 million for FY2024, which is 17613.37% up from last year.
  • Per Innoviva's latest filing, its Operating Expenses stood at $41.0 million for Q3 2025, which was up 3759.15% from $34.4 million recorded in Q2 2025.
  • Innoviva's 5-year Operating Expenses high stood at $87.7 million for Q2 2022, and its period low was -$219.2 million during Q3 2022.
  • In the last 5 years, Innoviva's Operating Expenses had a median value of $31.9 million in 2025 and averaged $12.8 million.
  • Data for Innoviva's Operating Expenses shows a peak YoY increase of 195637.6% (in 2022) and a maximum YoY decrease of 76575.94% (in 2022) over the last 5 years.
  • Over the past 5 years, Innoviva's Operating Expenses (Quarter) stood at -$25.3 million in 2021, then crashed by 765.76% to -$219.2 million in 2022, then surged by 91.47% to -$18.7 million in 2023, then surged by 259.26% to $29.8 million in 2024, then soared by 37.59% to $41.0 million in 2025.
  • Its last three reported values are $41.0 million in Q3 2025, $34.4 million for Q2 2025, and $31.9 million during Q1 2025.